Pharmafile Logo

Cuttsy+Cuttsy awarded CPD Platinum by the IPA

Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.

- PMLiVE

Platinum is only awarded to agencies who have reached gold level four years out of five and C+C have done it in their first four years of full membership of the IPA. In 2018 the agency team completed 905 hours of professional development vs. the 333 hours that agency needed to meet the IPA standard requirements.

On receiving the news Mathew Cutts, Co-Founder and Director spoke about the importance of the award ‘The workplace is evolving very quickly and attracting and retaining great people is no longer just about salary and a bonus. People are looking for many different aspects of employment, such as flexible working, having a career that makes a difference, progression and of course the chance to learn. This award is testament to the team and their thirst to want to continually improve it also evidences our commitment to the growth of individuals as well as the company’.

Kate McCabe, HR manager who is responsible for the initiative talked about what it takes to become a Platinum award winner. ‘Hard work and dedication, but more importantly, a commitment to truly investing in the belief that developing your team will not only develop and grow the business but motivate and retain the best people. Ultimately, providing a first-class service to your clients and for us most importantly, patients.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Empowering patients through more accessible clinical trial information

Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

The digital prescription – enhancing the patient experience with technology

We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...